Price $37.27 |
Market Cap
49.15B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
36.1
|
P/B
6.34
|
P/S
5.17
|
Dividend %
-
|
|
P/CF
96.0
|
P/FCF
113.2
|
Op. Cash Flow
917K
|
FCF
0.3
|
|
Op. Margin
15.70%
|
Net Margin
5.50%
|
ROE
7.10%
|
ROI
10.40%
|
|
ROA
2.70%
|
EPS Growth
-34.70%
|
Current Ratio
0.7
|
Debt/Equity
54.40%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Endo International PLC (ENDP) | $15.85 | - | - | 3.74B | Strong Buy |
| Vaxart Inc (VXRT) | $2.67 | - | - | 21.9M | Strong Buy |
| Procyon Corp (PCYN) | $0.23 | - | - | 2M | Strong Buy |
| Biostem Technologies Inc (BSEM) | $3.51 | - | - | 32M | Strong Buy |
| Cumberland Pharmaceuticals, In (CPIX) | $5.60 | - | - | 96.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
